Efficacy of a COMmunity-based WALKing programme with or without a pedometer on markers of glucose control, cardio-respiratory fitness and lung inflammation in Bahraini adults with type 2 diabetes: a pilot randomised controlled trial

Arabian Gulf University (Bahrain)0 个研究点目标入组 45 人开始时间: 2011年6月21日最近更新: 2016年10月17日

适应症

试验速览

暂无简介。

•1. Bahraini adults (aged 24-60 years) with type 2 diabetes (as defined by the American Diabetic Association, 1997) for more than 6 months
•2. A baseline haemoglobin A1c of 6.6% to 9.9%.

•1. Current insulin therapy
•2. Participation in exercise two or more times per week for more than or equal to 20 minutes/session during the previous 6 months
•3. Changes during the previous 2 months in oral hypoglycaemic, antihypertensive or lipid-lowering agents and body weight (more than or equal to 5%)
•4. Serum creatinine level of 200 µmol/L or greater
•5. Proteinuria greater than 1g/d
•6. Blood pressure greater than 160/95 mm Hg
•7. Restrictions in physical activity because of disease
•8. Presence of other medical conditions that make participation inadvisable

发起方

Arabian Gulf University (Bahrain)